Human papillomavirus, current vaccines, and cervical cancer prevention.
Human papillomavirus infection, the most common sexually transmitted infection in the United States, is associated with the development of cervical cancer. The new human papillomavirus vaccine advances cervical cancer prevention; however, provider-recommended screening with Papanicolaou tests and lifestyle modifications are still needed. Widespread implementation of the vaccine and delivering cervical cancer screening to underserved populations remain a challenge. Nurses are ideally suited to address these needs by providing education to patients and families.
Teitelman
Anne M
AM
Center for Health Disparities Research, School of Nursing, University of Pennsylvania, Philadelphia 19194-4217, USA. teitelm@nursing.upenn.edu
Stringer
Marilyn
M
Averbuch
Tali
T
Witkoski
Amy
A
D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D017589:Immunization Programs; D007115:Immunization Schedule; D008019:Life Style; D008403:Mass Screening / Q000379:methods* / Q000451:nursing; D024802:Nurse's Role; D065006:Papanicolaou Test; D030361:Papillomavirus Infections / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000191:economics / Q000276:immunology / Q000600:supply & distribution; D010353:Patient Education as Topic; D017410:Practice Guidelines as Topic; D011230:Precancerous Conditions / Q000517:prevention & control / Q000821:virology; D012307:Risk Factors; D040242:Risk Reduction Behavior; D012725:Sexual Behavior; D014481:United States / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology; D014626:Vaginal Smears
D053918:Papillomavirus Vaccines